Exothera
Fabien Baldacci-Cresp is an experienced analytical scientist and manager currently leading the Analytical Science Team at EXOTHERA since September 2020. Previous roles include a consultant at Novasep and post-doctoral researcher at Université de Lille Sciences et Technologies, where Fabien focused on functional glycobiology in plant biology. Additional post-doctoral research was conducted at Université Libre de Bruxelles, emphasizing plant development and health. A PhD in Biology of interactions and ecology was attained from Université Côte d'Azur, complemented by teaching assistant experience at Université Nice Sophia Antipolis. Fabien's expertise encompasses molecular biology, cell biology, microscopy, and microbiology, along with skills in project management, data analysis, and laboratory oversight.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660